GARACI, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 55.538
AS - Asia 6.281
EU - Europa 5.776
SA - Sud America 858
AF - Africa 55
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 16
Totale 68.550
Nazione #
US - Stati Uniti d'America 55.411
SG - Singapore 3.229
CN - Cina 1.685
UA - Ucraina 966
DE - Germania 859
BR - Brasile 738
IT - Italia 716
FR - Francia 589
HK - Hong Kong 576
PL - Polonia 563
IE - Irlanda 538
SE - Svezia 407
RU - Federazione Russa 390
GB - Regno Unito 312
KR - Corea 240
FI - Finlandia 232
VN - Vietnam 182
IN - India 76
CA - Canada 71
JP - Giappone 52
ES - Italia 45
AR - Argentina 43
BE - Belgio 40
NL - Olanda 35
ID - Indonesia 34
MX - Messico 33
BD - Bangladesh 32
TR - Turchia 29
UZ - Uzbekistan 24
EU - Europa 23
IL - Israele 21
IQ - Iraq 21
ZA - Sudafrica 19
AT - Austria 18
EC - Ecuador 18
CL - Cile 17
IR - Iran 16
AU - Australia 14
CZ - Repubblica Ceca 13
PK - Pakistan 12
AL - Albania 10
CO - Colombia 10
PY - Paraguay 10
EG - Egitto 9
AZ - Azerbaigian 8
VE - Venezuela 8
PE - Perù 7
SA - Arabia Saudita 7
CH - Svizzera 6
DK - Danimarca 6
LT - Lituania 6
JO - Giordania 5
KG - Kirghizistan 5
MA - Marocco 5
UY - Uruguay 5
AE - Emirati Arabi Uniti 4
DZ - Algeria 4
GR - Grecia 4
HN - Honduras 4
KE - Kenya 4
NI - Nicaragua 4
NP - Nepal 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
CR - Costa Rica 3
JM - Giamaica 3
LB - Libano 3
PH - Filippine 3
PS - Palestinian Territory 3
TN - Tunisia 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
DM - Dominica 2
DO - Repubblica Dominicana 2
KZ - Kazakistan 2
MD - Moldavia 2
NO - Norvegia 2
PA - Panama 2
SC - Seychelles 2
SK - Slovacchia (Repubblica Slovacca) 2
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MG - Madagascar 1
MN - Mongolia 1
MT - Malta 1
MU - Mauritius 1
MY - Malesia 1
Totale 68.539
Città #
Woodbridge 16.754
Wilmington 14.008
Houston 13.032
Ann Arbor 1.823
Fairfield 1.233
Singapore 1.153
Chandler 947
Jacksonville 891
Ashburn 823
Hong Kong 575
Beijing 560
Dublin 533
Kraków 522
Seattle 491
Zhengzhou 483
Cambridge 422
Medford 416
Dearborn 336
Rome 251
Santa Clara 225
Dallas 193
Lawrence 191
The Dalles 188
Los Angeles 168
Mülheim 152
New York 142
Buffalo 119
Shanghai 118
Council Bluffs 91
Menlo Park 86
Boardman 84
Hangzhou 83
San Diego 82
Moscow 77
Milan 73
San Mateo 60
Ho Chi Minh City 58
Falls Church 56
Munich 51
Hanoi 50
São Paulo 50
University Park 41
Chicago 39
Mountain View 39
Brussels 37
Guangzhou 36
Toronto 36
London 35
Columbus 33
Hefei 33
Redwood City 33
Nanjing 31
Warsaw 29
Norwalk 27
Verona 27
Kunming 25
Palo Alto 25
Belo Horizonte 23
Rio de Janeiro 23
Tokyo 23
Montreal 22
Turku 22
Denver 21
Brooklyn 20
Helsinki 19
Yongsan-gu 19
Jakarta 17
Porto Alegre 17
Saint Petersburg 17
Stockholm 17
Curitiba 15
Phoenix 15
Auburn Hills 14
Chennai 14
Nuremberg 14
Nürnberg 14
Brno 13
Detroit 13
Nanchang 13
Redondo Beach 13
San Francisco 13
Brasília 12
Frankfurt am Main 11
Jinan 11
North Bergen 11
Portici 11
Ankara 10
Johannesburg 10
Orem 10
Poplar 10
Salt Lake City 10
Washington 10
Atlanta 9
Baghdad 9
Dhaka 9
Florence 9
Fuzhou 9
Haikou 9
Madrid 9
Pune 9
Totale 58.775
Nome #
Thymosin α1 inserts N terminus into model membranes assuming a helical conformation 631
Thymosin alpha 1: from bench to bedside 593
Influence of cocaine on murine immune surveillance. 567
Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies 563
Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection. 557
Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice 553
Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance 528
Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice 526
Historical review on thymosin α1 in oncology: preclinical and clinical experiences 519
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 510
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats 508
A randomized controlled study for the evaluation of the activity of a triple combination of zidovudine, thymosin-alpha(1) and interferon-alpha in HIV-infected individuals with CD4 counts between 200 and 500 cells/mm(3) 507
Thymosin α1 Interacts with Exposed Phosphatidylserine in Membrane Models and in Cells and Uses Serum Albumin as a Carrier 499
Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer 498
Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2 488
Thymosin α1 inserts N terminus into model membranes assuming a helical conformation 486
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1 484
Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions 484
Imbalance in corneal redox state during herpes simplex virus 1-induced keratitis in rabbits. Effectiveness of exogenous glutathione supply 483
Effect of combined alpha IFN and prostaglandin A(1) treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells 481
ANTITUMOR EFFECT OF COMBINED TREATMENT WITH THYMOSIN ALPHA-1 AND INTERLEUKIN-2 AFTER 5-FLUOROURACIL IN LIVER METASTASES FROM COLORECTAL-CANCER IN RATS 481
Effects of cocaine administration to influenza virus-immunized mice on cytokine profiles of individual splenic CD4(+) and CD8(+) T cells 479
Analisi dell’espressione di retrovirus endogeni umani (HERV) in linfomonociti di soggetti sani di varie eta’: indicazioni per un possibile ruolo nello sviluppo 472
Fluconazole resistance in Candida albicans: a review of mechanisms. 471
Antiviral activity of cyclopentenone prostaglandins: Block of virus protein synthesis and induction of stress proteins in polarized monkey kidney cells 470
Human endogenous retroviruses and ADHD 469
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 467
Fluconazole resistance in Candida albicans: A review of mechanisms 466
activation of human endogenous retrovirus k and cellular modifications in human melanoma cell line: gene expression analysis 466
Inhibition of NF-κB activation sensitizes U937 cells to 3'-azido-3'-deoxythymidine induced apoptosis. 465
Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV 464
Intracellular GSH content and HIV replication in human macrophages 463
Combination low-dose lymphoblastoid interferon and thymosin alpha(1) therapy in the treatment of chronic hepatitis B 461
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 460
Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: Efficiency, metabolism and activity against human immunodeficiency virus or herpes simplex virus 460
Thymosin alpha 1 and HIV-1: Recent advances and future perspectives 460
Activation of human endogenous retrovirus k (herv-k) and cellular modifications in a human melanoma cell line: trascriptional profiling analysis 455
Inhibition of influenza A virus replication by resveratrol 453
INHIBITION OF RAT FIBROBLAST CELL-PROLIFERATION AT SPECIFIC CELL-CYCLE STAGES BY COCAINE 452
Macrophages and HIV infection: Therapeutical approaches toward this strategic virus reservoir 452
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 451
Effect of acute or daily cocaine administration on cellular immune response and virus infection in mice 450
Differential effects of acute morphine administrations on polymorphonuclear cell metabolism in various mouse strains 448
Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV 448
Effects of in vivo PGE2 administration on IL 2 production by splenocytes collected from normal and tumor-bearing mice . vol. 2, p. 31-40 447
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 447
Glutathione inhibits HIV replication by acting at late stages of the virus life cycle 446
Ruolo eziopatogenetico dei retrovirus endogeni umani: il caso del melanoma 445
Combined treatment with thymosin-alpha 1 and low dose interferon-alpha after dacarbazine in advanced melanoma 444
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death. 444
PCT (WO/2006/069812) RETROTRANSPOSON INHIBITION IN THERAPY 443
Adhd and human endogenous retroviruses 442
Herpesviruses and periodontal disease: a cautionary tale 438
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression 437
Activation of human endogenous retrovirus K (HERV-K) and cellular modifications in human melanoma cell line: transcriptional profiling analysis 437
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 435
Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 433
ACTIVATION OF HUMAN ENDOGENOUS RETROVIRUS K AND CELLULAR MODIFICATIONS IN HUMAN MELANOMA CELL LINE: GENE EXPRESSION ANALYSIS. 432
Cocaine potentiates the switch between latency and replication of Epstein-Barr virus in Raji cells. 431
Treatment of aspergillus infection with thymosin alpha 1 430
Anti-tumour immunogens and vaccines 429
In vivo recovery of natural killer cell activity by the association of thymosin α1 and cytokines during cocaine administration 428
Inhibition of endogenous reverse transcriptase antagonizes human tumor growth 427
Thymosin α1 and cancer: action on immune effector and tumor target cells 427
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis 427
Analisi filogenetica di un isolato di herv-k ottenuto da una lesione di melanoma metastatico umano. 425
Effect of thymosin alpha 1 on cocaine-induced inhibition of T cell dependent murine immune response. 422
Combination low-dose lymphoblastoid interferon and thymosin α1 therapy in the treatment of chronic hepatitis B 420
Modulatory role of PGE2 on IL-2 production after in vivo treatment. 418
New studies about the insertion mechanism of Thymosin α1 in negative regions of model membranes as starting point of the bioactivity 418
Cocaine effects on cell-cycle progression. 417
Depressed T-cell proliferation and polymorphonuclear superoxide anion production in mice treated with cocaine 415
Induction of apoptosis in thymocytes by prostaglandin E2 in vivo 415
INFLUENZA DEL MICROAMBIENTE SULLA PLASTICITA’ DI CELLULE DI MELANOMA ESPRIMENTI HERV-K. 415
Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling 413
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation 413
Effect of di-M-PGE2 on T cell differentiation. Flow cytometry study at thymus level 413
Inibitori Delle Istone Deacetilasi Riattivano Il Retrovirus Endogeno Umano-K In Cellule Di Melanoma Umano 412
Studies on the induction of human lymphocyte apoptosis by prostaglandin-E2 408
Thymosin-alpha 1 regulates MHC class I expression in FRTL-5 cells at transcriptional level 407
Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis 406
Thymosin αlpha1 potentiatesthe release of antiviral factors by cd8+ cells: new tools for antiviral therapy 406
Correlation between the effects of prostaglandins and interferon on B-16 melanoma growth and their modulation on natural killer activity 405
Combination therapy with BRMs in cancer and infectious diseases 405
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a 402
Effect of PGE2 on c-Myc and Bcl-2 production and programmed cell death in human lymphocytes. 402
MiR-34a regulates cell proliferation, morphology and function of newborn neurons resulting in improved behavioural outcomes 401
Azione antivirale delle prostaglandine: blocco della sintesi delle proteine virali ed induzione di proteine da stress in cellule di mammifero. 399
Studio sulla relazione esistente tra Nerve growth factor (NGF), infezione da Herpesvirus umano 8 (HHV-8 o KSHV) e patologie HHV-8-correlate. 399
Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection 397
comparative cellular signal patway analysis of metastatic colorectal cancer in human and preclinical animal model 396
Downregulation of thymosin beta4 in neural progenitor grafts promotes spinal cord regeneration 396
Cidofovir on HHV-8 in BCBL-1 cells 395
Modifications in spleen lymphocyte subsets after cyclophosphamide and 16,16-dimethyl prostaglandin E2 administration in mice 394
Inhibition of endogenous reverse transcriptase antagonizes human tumor growth 392
Retrotransposon inhibition in therapy 391
Human Endogenous Retroviruses-K (HERV-K) expression correlates with stemness features in melanoma cells. 388
null 387
Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application 387
Combination thymosin alpha(1) and lymphoblastoid interferon treatment in chronic hepatitis C 386
Totale 44.882
Categoria #
all - tutte 144.773
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.773


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20214.029 0 0 0 0 0 967 1.198 909 300 140 396 119
2021/20221.893 49 200 126 101 57 200 76 79 147 172 84 602
2022/20232.651 242 166 79 384 258 600 185 156 212 13 271 85
2023/2024837 105 30 65 33 83 147 103 59 16 17 18 161
2024/20255.550 169 961 573 303 155 338 344 274 458 359 897 719
2025/20263.005 589 335 861 581 568 71 0 0 0 0 0 0
Totale 68.904